Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-048400
Filing Date
2009-09-15
Accepted
2009-09-14 19:36:02
Documents
12
Period of Report
2009-05-31

Document Format Files

Seq Description Document Type Size
1 v160391_10k.htm 10-K 1331661
2 GRAPHIC chart1.jpg GRAPHIC 38029
3 GRAPHIC chart2.jpg GRAPHIC 68324
4 v160391_ex10-18.htm EX-10.18 74130
5 v160391_ex10-19.htm EX-10.19 76782
6 v160391_ex21-1.htm EX-21.1 3334
7 GRAPHIC ex21-1chart.jpg GRAPHIC 42315
8 v160391_ex31-1.htm EX-31.1 16211
9 v160391_ex31-2.htm EX-31.2 18253
10 v160391_ex32-1.htm EX-32.1 7271
11 v160391_ex32-2.htm EX-32.2 7271
12 v160391_ex99-11.htm EX-99.11 4753
  Complete submission text file 0001144204-09-048400.txt   1746545
Mailing Address 2820 W. CHARLESTON BLVD., SUITE 22 LAS VEGAS, NV 89102
Business Address 2820 W. CHARLESTON BLVD., SUITE 22 LAS VEGAS, NV 89102 000-000-0000
Sinobiopharma, Inc. (Filer) CIK: 0001403612 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 333-144910 | Film No.: 091068588
SIC: 2834 Pharmaceutical Preparations